Casa anatoly altura

Frontiers Case report: Short-term eculizumab use in atypical HUS

Por um escritor misterioso

Last updated 18 janeiro 2025

Frontiers Case report: Short-term eculizumab use in atypical HUS

PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome

The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome - ScienceDirect

Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study

Frontiers Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation

PDF) Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab

PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses

PDF) Anti-factor H antibody and its role in atypical hemolytic uremic syndrome

Pregnancy associated atypical hemolytic uremic syndrome presenting with preeclampsia with HELLP syndrome and following treatment with Eculizumab

Diagnostic and Risk Factors for Complement Defects in Hypertensive Emergency and Thrombotic Microangiopathy

Short-term use of Soliris treats two cases of aHUS not tied to mutations

Frontiers Case report: Short-term eculizumab use in atypical HUS associated with Lemierre's syndrome and post-infectious glomerulonephritis

Recomendado para você